Panagora Asset Management’s Theravance Biopharma TBPH Stock Holding History

Panagora Asset Management’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-103,049	Closed	-$1.05M	–	1508
2022 Q3	$1.05M	Hold	103,049	–	–	0.01%	843
2022 Q2	$934K	Sell	103,049 -167,642	-62%	-$1.52M	0.01%	905
2022 Q1	$2.59M	Buy	270,691 +11,296	+4%	+$108K	0.01%	611
2021 Q4	$2.87M	Buy	259,395 +83,721	+48%	+$925K	0.02%	537
2021 Q3	$1.3M	Sell	175,674 -3,526	-2%	-$26.1K	0.01%	851
2021 Q2	$2.6M	Sell	179,200 -7,915	-4%	-$115K	0.01%	634
2021 Q1	$3.82M	Buy	187,115 +2,128	+1%	+$43.4K	0.02%	538
2020 Q4	$3.29M	Buy	184,987 +90,026	+95%	+$1.6M	0.02%	540
2020 Q3	$1.4M	Buy	94,961 +106	+0.1%	+$1.57K	0.01%	776
2020 Q2	$1.99M	Buy	+94,855	New	+$1.99M	0.01%	673
2019 Q2	–	Sell	-3,111	Closed	-$71K	–	2674
2019 Q1	$71K	Hold	3,111	–	–	﹤0.01%	1966
2018 Q4	$80K	Hold	3,111	–	–	﹤0.01%	1864
2018 Q3	$102K	Hold	3,111	–	–	﹤0.01%	1856
2018 Q2	$70K	Hold	3,111	–	–	﹤0.01%	1962
2018 Q1	$75K	Hold	3,111	–	–	﹤0.01%	1925
2017 Q4	$87K	Hold	3,111	–	–	﹤0.01%	1918
2017 Q3	$107K	Sell	3,111 -68,722	-96%	-$2.36M	﹤0.01%	1870
2017 Q2	$2.86M	Buy	71,833 +908	+1%	+$36.2K	0.01%	741
2017 Q1	$2.61M	Sell	70,925 -1,642	-2%	-$60.4K	0.01%	784
2016 Q4	$2.31M	Sell	72,567 -93,014	-56%	-$2.96M	0.01%	842
2016 Q3	$6M	Sell	165,581 -46,534	-22%	-$1.69M	0.03%	507
2016 Q2	$4.81M	Buy	212,115 +34,203	+19%	+$776K	0.02%	567
2016 Q1	$3.35M	Buy	177,912 +72,418	+69%	+$1.36M	0.02%	695
2015 Q4	$1.73M	Buy	105,494 +36,188	+52%	+$593K	0.01%	868
2015 Q3	$762K	Buy	69,306 +7,298	+12%	+$80.2K	﹤0.01%	1155
2015 Q2	$807K	Buy	62,008 +19,312	+45%	+$251K	﹤0.01%	1178
2015 Q1	$741K	Buy	42,696 +13,888	+48%	+$241K	﹤0.01%	1179
2014 Q4	$430K	Sell	28,808 -8,319	-22%	-$124K	﹤0.01%	1341
2014 Q3	$856K	Sell	37,127 -133	-0.4%	-$3.07K	﹤0.01%	1114
2014 Q2	$1.19M	Buy	+37,260	New	+$1.19M	0.01%	1035